SS
Shiladitya Sengupta
About Shiladitya Sengupta
Data last updated:
Shiladitya Sengupta is a Director at Vyome Therapeutics Limited (since 2017), Director at Invictus Oncology Private Limited (since 2011) and Director at India Innovation Research Center (since 2011), and holds 2 more current directorships. The companies operate in Pharma, Travel and Hospitality and Life Sciences. The 5 current companies with reported revenue have a combined latest revenue of ₹6.24 Cr; the largest is Vyome Therapeutics Limited at ₹3.35 Cr (FY 2025). Earlier, Shiladitya Sengupta was a Director at Mitra Life Sciences India Private Limited (from 2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Aug 2017 | 2017 | ₹3.35 Cr (FY 2025) | Active | |
| Director | 11 Apr 2011 | 2011 | ₹2.86 Cr (FY 2025) | Active | |
| Director | 26 Dec 2011 | 2011 | ₹1.9 Lakh (FY 2025) | Active | |
| Director | 19 Aug 2010 | 2010 | ₹40,161 (FY 2025) | Active | |
| Director | 30 Aug 2017 | 2017 | ₹9,100 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Apr 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shiladitya Sengupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Raghunath Anant Mashelkar | 00074119 | Vyome Therapeutics Limited , Invictus Oncology Private Limited and 1 more | Director |
| Ranjana Kumar | 02930881 | Vyome Therapeutics Limited , Vyome Biosciences Private Limited | Director |
| Sivaram Swaminathan | 00009900 | Vyome Therapeutics Limited | Director |
| Venkateswarlu Nelabhotla | 03288992 | Vyome Therapeutics Limited , Vyome Biosciences Private Limited | Director |
| Jasmin Rambhai Patel | 06396028 | Invictus Oncology Private Limited | Nominee Director |
| Rajeev Mantri | 01895901 | Invictus Oncology Private Limited , Vyome Biosciences Private Limited and 1 more | Nominee Director |
| Syamal Kumar Sen Gupta | 10471786 | India Innovation Research Center | Director |
| Krishna Kumar Gupta | 07948574 | Vyome Biosciences Private Limited | Director |
| Shrikant Mantri | 01240147 | Akamara Biomedicine Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shiladitya Sengupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shiladitya Sengupta
Shiladitya Sengupta currently holds 5 directorships: Vyome Therapeutics Limited (Director, since 30 Aug 2017, revenue ₹3.35 Cr (FY 2025)); Invictus Oncology Private Limited (Director, since 11 Apr 2011, revenue ₹2.86 Cr (FY 2025)); India Innovation Research Center (Director, since 26 Dec 2011, revenue ₹1.9 Lakh (FY 2025)); Vyome Biosciences Private Limited (Director, since 19 Aug 2010, revenue ₹40,161 (FY 2025)); Akamara Biomedicine Private Limited (Director, since 30 Aug 2017, revenue ₹9,100 (FY 2024)).
Shiladitya Sengupta was first appointed on 23 Apr 2008 as Director at Mitra Life Sciences India Private Limited. The most recent appointment on record is 30 Aug 2017 at Akamara Biomedicine Private Limited.
The 5 current companies of Shiladitya Sengupta that report revenue have a combined latest revenue of ₹6.24 Cr: Vyome Therapeutics Limited ₹3.35 Cr (FY 2025); Invictus Oncology Private Limited ₹2.86 Cr (FY 2025); India Innovation Research Center ₹1.9 Lakh (FY 2025); Vyome Biosciences Private Limited ₹40,161 (FY 2025); Akamara Biomedicine Private Limited ₹9,100 (FY 2024).
Shiladitya Sengupta held 1 earlier board appointment: Mitra Life Sciences India Private Limited (Director, from 23 Apr 2008).
The current boards of Shiladitya Sengupta's companies include Raghunath Anant Mashelkar (Vyome Therapeutics Limited), Ranjana Kumar (Vyome Therapeutics Limited), Sivaram Swaminathan (Vyome Therapeutics Limited), Venkateswarlu Nelabhotla (Vyome Therapeutics Limited), Jasmin Rambhai Patel (Invictus Oncology Private Limited), Rajeev Mantri (Invictus Oncology Private Limited), among others.